Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Enokida

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
BMC Cancer|January 12, 2021
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancerShunsuke Okamura, Hirofumi Yoshino, Kazuki Kuroshima, et al.
International Journal of Oncology|May 9, 2015
The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancerNoriko Yamamoto, Rika Nishikawa, Takeshi Chiyomaru, et al.
Oncotarget|May 26, 2018
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinomaTakashi Sakaguchi, Hirofumi Yoshino, Satoshi Sugita, et al.
Cancer Science|December 21, 2010
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytologyYasutoshi Yamada, Hideki Enokida, Satoko Kojima, et al.
The Journal of Urology|July 12, 2014
Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinomaTomoaki Ishihara, Naohiko Seki, Satoru Inoguchi, et al.
Molecular Oncology|December 21, 2025
Therapeutic strategies for MMAE-resistant bladder cancer through DPP4 inhibitionGang Li, Shuichi Tatarano, Hirofumi Yoshino, et al.
World Journal of Urology|January 16, 2007
Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the ratShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNAShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
International Journal of Oncology|June 25, 2011
Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinomaNijiro Nohata, Toyoyuki Hanazawa, Naoko Kikkawa, et al.
Japanese Journal of Cancer Research : Gann|October 3, 2002
Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell lineHideki Enokida, Takenari Gotanda, Shoichi Oku, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
BMC Cancer|January 12, 2021
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancerShunsuke Okamura, Hirofumi Yoshino, Kazuki Kuroshima, et al.
International Journal of Oncology|May 9, 2015
The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancerNoriko Yamamoto, Rika Nishikawa, Takeshi Chiyomaru, et al.
Oncotarget|May 26, 2018
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinomaTakashi Sakaguchi, Hirofumi Yoshino, Satoshi Sugita, et al.
Cancer Science|December 21, 2010
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytologyYasutoshi Yamada, Hideki Enokida, Satoko Kojima, et al.
The Journal of Urology|July 12, 2014
Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinomaTomoaki Ishihara, Naohiko Seki, Satoru Inoguchi, et al.
Molecular Oncology|December 21, 2025
Therapeutic strategies for MMAE-resistant bladder cancer through DPP4 inhibitionGang Li, Shuichi Tatarano, Hirofumi Yoshino, et al.
World Journal of Urology|January 16, 2007
Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the ratShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNAShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
International Journal of Oncology|June 25, 2011
Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinomaNijiro Nohata, Toyoyuki Hanazawa, Naoko Kikkawa, et al.
Japanese Journal of Cancer Research : Gann|October 3, 2002
Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell lineHideki Enokida, Takenari Gotanda, Shoichi Oku, et al.
Pageof 18